» Articles » PMID: 34093208

The Research Progress of Exosomes in Osteoarthritis, With Particular Emphasis on the Mediating Roles of MiRNAs and LncRNAs

Overview
Journal Front Pharmacol
Date 2021 Jun 7
PMID 34093208
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoarthritis (OA) is a kind of degenerative disease, which is caused by many factors such as aging, obesity, strain, trauma, congenital joint abnormalities, joint deformities. Exosomes are mainly derived from the invagination of intracellular lysosomes, which are released into the extracellular matrix after fusion of the outer membrane of multi vesicles with the cell membrane. Exosomes mediate intercellular communication and regulate the biological activity of receptor cells by carrying non-coding RNA, long noncoding RNAs (lncRNAs), microRNAs (miRNAs), proteins and lipids. Evidences show that exosomes are involved in the pathogenesis of OA. In view of the important roles of exosomes in OA, this paper systematically reviewed the roles of exosomes in the pathogenesis of OA, including the roles of exosomes in OA diagnosis, the regulatory mechanisms of exosomes in the pathogenesis, and the intervention roles of exosomes in the treatment of OA. Reviewing the roles of exosomes in OA will help to clarify the pathogenesis of OA and explore new diagnostic biomarkers and therapeutic targets.

Citing Articles

Potential and challenges of utilizing exosomes in osteoarthritis therapy (Review).

Chen X, Tian B, Wang Y, Zheng J, Kang X Int J Mol Med. 2025; 55(3).

PMID: 39791222 PMC: 11759586. DOI: 10.3892/ijmm.2025.5484.


Extracellular Vesicles: A Novel Diagnostic Tool and Potential Therapeutic Approach for Equine Osteoarthritis.

Elashry M, Speer J, De Marco I, Klymiuk M, Wenisch S, Arnhold S Curr Issues Mol Biol. 2024; 46(11):13078-13104.

PMID: 39590374 PMC: 11593097. DOI: 10.3390/cimb46110780.


Current Non-Surgical Curative Regenerative Therapies for Knee Osteoarthritis.

Bahari Golamkaboudi A, Vojoudi E, Roshani K, Porouhan P, Houshangi D, Barabadi Z Stem Cell Rev Rep. 2024; 20(8):2104-2123.

PMID: 39145857 DOI: 10.1007/s12015-024-10768-6.


Exosomes in Osteoarthritis: A Review on Their Isolation Techniques and Therapeutic Potential.

Syed N, Misbah I, Azlan M, Ahmad Mohd Zain M, Nurul A Indian J Orthop. 2024; 58(7):866-875.

PMID: 38948378 PMC: 11208382. DOI: 10.1007/s43465-024-01175-7.


Nanomaterials-assisted gene editing and synthetic biology for optimizing the treatment of pulmonary diseases.

Lei L, Pan W, Shou X, Shao Y, Ye S, Zhang J J Nanobiotechnology. 2024; 22(1):343.

PMID: 38890749 PMC: 11186260. DOI: 10.1186/s12951-024-02627-w.


References
1.
Sun H, Hu S, Zhang Z, Lun J, Liao W, Zhang Z . Expression of exosomal microRNAs during chondrogenic differentiation of human bone mesenchymal stem cells. J Cell Biochem. 2018; 120(1):171-181. DOI: 10.1002/jcb.27289. View

2.
Qiong J, Xia Z, Jing L, Haibin W . Synovial mesenchymal stem cells effectively alleviate osteoarthritis through promoting the proliferation and differentiation of meniscus chondrocytes. Eur Rev Med Pharmacol Sci. 2020; 24(4):1645-1655. DOI: 10.26355/eurrev_202002_20338. View

3.
Wang Y, Xie Y, Zhang A, Wang M, Fang Z, Zhang J . Exosomes: An emerging factor in atherosclerosis. Biomed Pharmacother. 2019; 115:108951. DOI: 10.1016/j.biopha.2019.108951. View

4.
ONeill T, Felson D . Mechanisms of Osteoarthritis (OA) Pain. Curr Osteoporos Rep. 2018; 16(5):611-616. PMC: 6153568. DOI: 10.1007/s11914-018-0477-1. View

5.
Xu X, Liang Y, Li X, Ouyang K, Wang M, Cao T . Exosome-mediated delivery of kartogenin for chondrogenesis of synovial fluid-derived mesenchymal stem cells and cartilage regeneration. Biomaterials. 2020; 269:120539. DOI: 10.1016/j.biomaterials.2020.120539. View